Hugh Johnson Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,162
Closed -$2.18M 86
2018
Q3
$2.18M Buy
6,162
+70
+1% +$24.1K 0.6% 43
2018
Q2
$1.77M Buy
6,092
+145
+2% +$40.8K 0.51% 47
2018
Q1
$1.63M Sell
5,947
-60
-1% -$18.6K 0.49% 51
2017
Q4
$1.91M Buy
6,007
+12
+0.2% +$3.85K 0.56% 48
2017
Q3
$1.88M Buy
5,995
+35
+0.6% +$10.4K 0.56% 48
2017
Q2
$1.62M Sell
5,960
-55
-0.9% -$14.5K 0.52% 53
2017
Q1
$1.65M Buy
6,015
+60
+1% +$17K 0.54% 54
2016
Q4
$1.69M Buy
5,955
+245
+4% +$72.6K 0.58% 53
2016
Q3
$1.79M Buy
5,710
+65
+1% +$19.3K 0.66% 51
2016
Q2
$1.36M Buy
5,645
+265
+5% +$69.8K 0.53% 51
2016
Q1
$1.4M Buy
5,380
+45
+0.8% +$11.9K 0.55% 54
2015
Q4
$1.63M Sell
5,335
-3,825
-42% -$1.1M 0.62% 53
2015
Q3
$2.67M Sell
9,160
-90
-1% -$29.7K 1.08% 36
2015
Q2
$3.74M Sell
9,250
-65
-0.7% -$26.1K 1.32% 31
2015
Q1
$3.93M Buy
+9,315
New +$3.67M 1.32% 34

Other funds holding BIIB

Hugh Johnson Advisors's BIIB Position: Q4 2018 in Review

Hugh Johnson Advisors sold out of Biogen (BIIB) in Q4 2018, closing a stake of 6,162 shares — an estimated $2.18M sold.

Hugh Johnson Advisors first reported a position in BIIB in Q1 2015 and held it in 15 quarters. The position peaked at $3.93M in Q1 2015. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Hugh Johnson Advisors reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Hugh Johnson Advisors sold 6,162 Biogen shares in Q4 2018, an estimated $2.18M.
  • Hugh Johnson Advisors first reported a position in Biogen in Q1 2015 and held it in 15 quarters.
  • Hugh Johnson Advisors's Biogen position peaked at $3.93M in Q1 2015.
  • 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Hugh Johnson Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.